WARTICON 0.5%w/v %w/v Cutaneous Solution Īrija - angļu - HPRA (Health Products Regulatory Authority)

warticon 0.5%w/v %w/v cutaneous solution

stiefel laboratories (u.k.) ltd. - podophyllotoxin - cutaneous solution - 0.5%w/v %w/v

Wartec Cream Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

wartec cream

glaxosmithkline australia pty ltd - podophyllotoxin -

Wartec Solution Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

wartec solution

glaxosmithkline australia pty ltd - podophyllotoxin -

CONDYLINE SOLUTION Kanāda - angļu - Health Canada

condyline solution

sanofi-aventis canada inc - podophyllotoxin - solution - 0.5% - podophyllotoxin 0.5% - misc. skin and mucous membrane agents

Warticon 0.15% w/w Cream Malta - angļu - Medicines Authority

warticon 0.15% w/w cream

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - podophyllotoxin - cream - podophyllotoxin 1.5 mg/g - antibiotics and chemotherapeutics for dermatological use

Warticon 0.15% w/w Cream Malta - angļu - Medicines Authority

warticon 0.15% w/w cream

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - podophyllotoxin - cream - podophyllotoxin 1.5 mg/g - antibiotics and chemotherapeutics for dermatological use

ETOPOSIDE 20 Mg/Ml Concentrate for Soln for Inf Īrija - angļu - HPRA (Health Products Regulatory Authority)

etoposide 20 mg/ml concentrate for soln for inf

cipla (eu) limited - etoposide - concentrate for soln for inf - 20 mg/ml - podophyllotoxin derivatives - it is indicated in adults for the management of: resistant non-seminomatous testicular tumours in combination with other chemotherapeutic agents; small cell lung cancer, in combination with other chemotherapeutic agents; acute monoblastic leukaemia (aml m5) and acute myelomonoblastic leukaemia (aml m4) when standard induction therapy has failed (in combination with other chemotherapeutic agents).

Wartec Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

wartec

universal specialities ltd trading as usl medical - podophyllotoxin 0.5%{relative} (includes overage to 0.569%) - topical solution - 5 mg/ml - active: podophyllotoxin 0.5%{relative} (includes overage to 0.569%) excipient: ethanol patent blue v phosphoric acid purified water

WARTICON Cutaneous Solution 0.5%w/v %w/v Īrija - angļu - HPRA (Health Products Regulatory Authority)

warticon cutaneous solution 0.5%w/v %w/v

stiefel laboratories (u.k.) ltd. - podophyllotoxin - cutaneous solution - 0.5%w/v %w/v

Wartec Cream 0.15 % Bahreina - angļu - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wartec cream 0.15 %

behzad pharmacy - podophyllotoxin - cream - 0.15